The latest closing stock price for Supernus Pharmaceuticals as of November 20, 2024 is 36.12.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $5,726 today, roughly 6 times their original investment - a 15.79% compound annual growth rate over 13 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 39.37, which is 9% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 29.3% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 30.42.
An investor who bought $1,000 worth of Supernus Pharmaceuticals stock at the IPO in 2012 would have $5,726 today, roughly 6 times their original investment - a 15.79% compound annual growth rate over 13 years.
The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
The Supernus Pharmaceuticals 52-week high stock price is 39.37, which is 9% above the current share price.
The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 29.3% below the current share price.
The average Supernus Pharmaceuticals stock price for the last 52 weeks is 30.42.